NCT05997342 2025-08-11
A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Completed
Clinical Trials
7 trialsNCT06344351 2025-05-22
A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Completed
NCT03122886 2024-12-17
Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin
Mayo Clinic
Phase NA Completed
NCT02823652 2024-02-28
Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer
Eastern Cooperative Oncology Group
Phase NA Completed
NCT01867294 2020-01-09
Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab
Academic and Community Cancer Research United
Phase 2 Completed
NCT02650583 2019-02-15
Enhancing Connections Program in Improving Communication Between Patients With Incurable Cancer and Their Children
University of Washington
Phase NA Completed
NCT00244972 2017-04-27
Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer
National Cancer Institute (NCI)
Phase 1 Completed